Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea
· Delayed Price · Currency is KRW 4,110.00
+80.00 (1.99%)
Apr 1, 2025, 3:30 PM KST
Komipharm International Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 58,779 | 42,647 | 39,801 | 35,847 | 37,160 | Upgrade
|
| Other Revenue | - | - | - | -0 | - | Upgrade
|
| Revenue | 58,779 | 42,647 | 39,801 | 35,847 | 37,160 | Upgrade
|
| Revenue Growth (YoY) | 37.83% | 7.15% | 11.03% | -3.53% | 4.71% | Upgrade
|
| Cost of Revenue | 37,146 | 30,120 | 28,485 | 24,741 | 23,857 | Upgrade
|
| Gross Profit | 21,633 | 12,527 | 11,316 | 11,107 | 13,303 | Upgrade
|
| Selling, General & Admin | 11,741 | 10,459 | 10,004 | 9,127 | 9,907 | Upgrade
|
| Research & Development | 2,466 | 5,945 | 2,536 | 5,117 | 3,266 | Upgrade
|
| Other Operating Expenses | 236.76 | 243.5 | 251.86 | 220.89 | 215.79 | Upgrade
|
| Operating Expenses | 15,440 | 18,800 | 15,119 | 16,397 | 15,478 | Upgrade
|
| Operating Income | 6,193 | -6,273 | -3,804 | -5,291 | -2,175 | Upgrade
|
| Interest Expense | -3,206 | -2,552 | -2,216 | -1,657 | -1,549 | Upgrade
|
| Interest & Investment Income | 707.18 | 678.36 | 227.68 | 140.21 | 165.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,109 | 235.11 | 474.93 | 1,129 | -217.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 2,781 | 2,106 | 940.07 | 51.94 | -447.5 | Upgrade
|
| EBT Excluding Unusual Items | 7,585 | -5,805 | -4,377 | -5,626 | -4,224 | Upgrade
|
| Gain (Loss) on Sale of Investments | -123.27 | 248.7 | - | 13.59 | 122.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | 9,073 | 64.42 | -2.43 | 0.81 | 144.51 | Upgrade
|
| Asset Writedown | -1,845 | -247.4 | -3,100 | -323 | - | Upgrade
|
| Pretax Income | 14,690 | -5,739 | -7,480 | -5,934 | -3,957 | Upgrade
|
| Income Tax Expense | - | 171.15 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | 14,690 | -5,911 | -7,480 | -5,934 | -3,957 | Upgrade
|
| Minority Interest in Earnings | -1,577 | 1,932 | 965.91 | 1,475 | 1,141 | Upgrade
|
| Net Income | 13,113 | -3,979 | -6,514 | -4,459 | -2,816 | Upgrade
|
| Net Income to Common | 13,113 | -3,979 | -6,514 | -4,459 | -2,816 | Upgrade
|
| Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 70 | 70 | 70 | 70 | Upgrade
|
| Shares Change (YoY) | -0.66% | -0.18% | 0.01% | 0.09% | 0.37% | Upgrade
|
| EPS (Basic) | 188.17 | -56.72 | -92.68 | -63.45 | -40.10 | Upgrade
|
| EPS (Diluted) | 188.00 | -57.00 | -93.00 | -63.64 | -40.10 | Upgrade
|
| Free Cash Flow | 7,802 | -3,437 | -2,656 | -2,069 | -1,631 | Upgrade
|
| Free Cash Flow Per Share | 111.95 | -48.99 | -37.78 | -29.45 | -23.22 | Upgrade
|
| Gross Margin | 36.80% | 29.37% | 28.43% | 30.98% | 35.80% | Upgrade
|
| Operating Margin | 10.54% | -14.71% | -9.56% | -14.76% | -5.85% | Upgrade
|
| Profit Margin | 22.31% | -9.33% | -16.37% | -12.44% | -7.58% | Upgrade
|
| Free Cash Flow Margin | 13.27% | -8.06% | -6.67% | -5.77% | -4.39% | Upgrade
|
| EBITDA | 9,293 | -2,744 | 22.34 | -1,708 | 1,565 | Upgrade
|
| EBITDA Margin | 15.81% | -6.43% | 0.06% | -4.76% | 4.21% | Upgrade
|
| D&A For EBITDA | 3,100 | 3,529 | 3,826 | 3,582 | 3,740 | Upgrade
|
| EBIT | 6,193 | -6,273 | -3,804 | -5,291 | -2,175 | Upgrade
|
| EBIT Margin | 10.54% | -14.71% | -9.56% | -14.76% | -5.85% | Upgrade
|
| Advertising Expenses | 408.7 | 256.75 | 227.89 | 206.18 | 153.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.